[August 19, 2026] The New MedTech Battleground. Is the future of MedTech innovation shifting away from devices—and toward manufacturing?

In this episode of Med Tech Gurus, we sit down with Mark Freitas, Managing Director and Life Sciences Leader at Alvarez & Marsal, to explore a major shift happening in MedTech: capital is moving away from traditional device acquisitions and toward advanced manufacturing platforms and CDMOs.

As device complexity increases and technologies converge across hardware, software, and biologics, the ability to manufacture at scale is becoming a strategic differentiator—not just an operational function.

Mark breaks down why 2026 is shaping up to be a pivotal year for MedTech M&A, with a surge in deal activity driven by private equity exits, OEM carve-outs, and platform roll-ups. He explains why scarcity of specialized capabilities—not revenue—is now driving valuation, and how regulatory infrastructure has emerged as a hidden but powerful competitive moat.

We also explore how founders and operators should think about CDMO partnerships, when to own manufacturing versus outsource it, and why many companies get the timing wrong.

For MedTech leaders, investors, and innovators, this episode delivers a clear message: the winners in the next wave of MedTech won’t just build great products—they’ll build (or partner for) the capabilities to make them.

[August 12, 2026] When Cyber Attacks Become Patient Events. Cybersecurity in healthcare is no longer an IT issue—it’s a patient safety issue.

In this episode of Med Tech Gurus, we sit down with Skip Sorrels, Field CTO and Chief Information Security Officer at Claroty, to explore how cyber threats are evolving from data breaches into full-scale clinical and operational disruptions.

With a unique background as both an ICU nurse and healthcare cybersecurity leader, Skip brings a rare perspective on what actually happens inside a hospital when systems go down. From electronic medical records shutting off to clinicians reverting to paper processes, these events don’t just slow operations—they fundamentally impact patient outcomes.

We dive into the growing risks tied to connected medical devices and hospital infrastructure, including operational technologies like HVAC systems, water filtration, and building controls—areas increasingly targeted as the “path of least resistance” for attackers.

Skip also shares why healthcare organizations must begin treating cybersecurity like disaster preparedness, focusing on operational resilience, recovery planning, and real-world readiness—not just prevention.

For MedTech innovators, this episode delivers a critical message: security is no longer a feature—it’s a requirement for trust, adoption, and patient safety.

If you're interested in healthcare cybersecurity, medical device security, hospital operations, digital health risk, or MedTech commercialization, this episode offers a powerful and timely perspective on one of the most important challenges facing healthcare today.

[August 5, 2026] Why Great Medtech Doesn’t Get Adopted. Why do breakthrough medical technologies still fail to get adopted?

In this episode of Med Tech Gurus, we sit down with David Neale, Co-Founder and CEO of Argá  MedTech, to explore what it really takes to bring a differentiated cardiac technology from concept to clinical adoption.

Argá is advancing next-generation pulsed field ablation (PFA) for the treatment of atrial fibrillation, with early data showing 100% procedural success, strong safety, and high lesion durability. But as David explains, great clinical data alone isn’t enough.

Drawing on decades of experience in cardiac rhythm management, David shares why so many promising technologies fail—not because of engineering, but because they ignore physician workflow, hospital operations, and real-world usability. From designing a single, multi-configurable catheter platform to simplifying complex EP lab environments, Argá’s strategy is built around one principle: innovation must fit the workflow to win adoption.

We dive into lessons from first-in-human trials, the importance of disciplined execution, and why companies must design for three critical stakeholders: clinicians, operational teams, and administrators. David also shares practical insights on site selection, physician alignment, and how to move from strong data to real-world adoption.

If you're interested in cardiac electrophysiology, pulsed field ablation, MedTech commercialization, clinical trials, or healthcare innovation, this episode delivers a powerful playbook for turning technology into adoption.

[July 29, 2026] The Diagnostic Odyssey: What Healthcare Gets Wrong About Patients. What does it really mean to put the patient at the center of healthcare innovation?

In this episode of Med Tech Gurus, we sit down with Stephanie Hunter-Banks of Jazz Pharmaceuticals, a leader in medical learning, patient engagement, and rare disease advocacy. But what makes this conversation truly powerful is that Stephanie doesn’t just study the patient journey—she lives it.

As a rare disease patient herself, Stephanie brings a deeply personal and professional perspective to how healthcare systems, MedTech companies, and clinicians engage with patients. Her journey—spanning more than two decades without a definitive diagnosis—offers a raw and honest look into what many patients experience but few organizations truly understand.

Stephanie shares why scientific innovation alone isn’t enough—and how empathy, trust, and meaningful engagement are critical to driving better outcomes. From the challenges of the “diagnostic odyssey” to the importance of resilience, she provides a framework for how healthcare leaders can rethink patient-centricity—not as a buzzword, but as a real partnership.

We also explore the role of medical affairs in translating complex science into real-world clinical decisions, the gaps that still exist between providers and patients, and how leaders can build teams grounded in trust, connection, and growth.

If you're interested in rare disease, patient engagement, medical affairs, healthcare leadership, or MedTech innovation, this episode delivers a powerful reminder: the future of healthcare isn’t just about better technology—it’s about better understanding the people it serves.

[July 22, 2026] Time Is Lives. In rare disease, time isn’t money—it’s lives.

In this episode of Med Tech Gurus, we sit down with Dr. Rob Freishtat, physician-scientist, former President and Co-Founder of Uncommon Cures, and board member of the Foundation for mRNA Medicines, to explore how clinical trial design is being rewritten for rare and ultra-rare conditions.

Traditional randomized, placebo-controlled trials—largely unchanged for decades—are often too rigid, too slow, and too burdensome for patients facing life-threatening conditions. Dr. Freishtat shares why adaptive trial designs, natural history cohorts, and patient-centric approaches are becoming essential to accelerating drug development.

We dive into the rise of N-of-1 therapies, mRNA-based treatments, and collaborative models that bring together regulators, academic centers, and industry in ways that were previously unthinkable. From the groundbreaking “Baby KJ” case to emerging ARPA-H initiatives, this conversation highlights a fundamental shift toward truly personalized medicine.

Dr. Freishtat also offers practical insights for founders navigating today’s capital environment—why smaller, more efficient trials can unlock new funding pathways, and how aligning with mission-driven investors can accelerate both impact and execution.

If you're interested in rare disease innovation, clinical trial design, mRNA therapies, personalized medicine, or biotech startup strategy, this episode delivers a powerful look at how urgency is reshaping the future of healthcare.

[July 15, 2026] The End of ‘See One, Do One, Teach One’. What if the future of surgical training doesn’t happen in the operating room?

In this episode of Med Tech Gurus, we sit down with Dr. Danny Goel, orthopedic surgeon, clinical professor at the University of British Columbia, and CEO & co-founder of Precision OS, to explore how virtual reality and AI are transforming surgical education.

Today’s training environment is under pressure—reduced clinical hours, increasing procedural complexity, and a relentless focus on operating room efficiency are limiting opportunities for hands-on learning. The traditional “see one, do one, teach one” model is no longer enough.

Dr. Goel shares how Precision OS is addressing this challenge with immersive VR simulation that allows surgeons to practice procedures on demand, receive objective performance feedback, and improve skills outside the operating room. With over 100+ orthopedic training modules and the ability to capture detailed performance data, the platform is redefining how surgical competency is measured and developed.

We explore the shift from subjective evaluation to data-driven skill assessment, the importance of workflow integration for adoption, and how just-in-time training can improve both surgeon confidence and patient outcomes.

If you're interested in medical education, surgical simulation, AI in healthcare, virtual reality training, or MedTech innovation, this episode offers a compelling look at how technology is reshaping the future of surgical training.

[July 8, 2026] Visibility Is The New Currency. In this episode of Med Tech Gurus, we sit down with Lauren Schafer, Founder of Lakehouse Digital Media, to explore why so many MedTech and life sciences companies struggle to gain traction—not because of weak innovation, but because of weak visibility and storytelling.

Lauren works with founders and leadership teams to turn expertise into credibility, helping companies show up where investors, clinicians, and decision-makers are actually evaluating solutions. From LinkedIn thought leadership to modern SEO strategies shaped by AI, her approach focuses on one core idea: if you’re not part of the conversation, you’re not part of the decision.

We dive into why traditional SEO is rapidly evolving, how platforms like LinkedIn and podcasts are becoming primary drivers of discovery, and why long-form, conversational content is now critical for AI search visibility. Lauren also shares practical strategies for repurposing content, maximizing conference ROI, and building a scalable marketing engine through fractional teams.

If you're a MedTech founder, healthcare executive, or startup leader looking to break through the noise and accelerate growth, this episode delivers a practical playbook for turning visibility into real business momentum.

[July 1, 2026] Why Telehealth Isn’t Just A Video Call. Access to care remains one of healthcare’s biggest challenges—especially in physical therapy, where patients often travel hours for a single appointment.

In this episode of Med Tech Gurus, we sit down with Dr. Ashok Gupta, founder and CEO of TheraNow, a rapidly growing virtual physical therapy platform that has treated more than 70,000 patients nationwide through a network of over 400 therapists.

Ashok’s journey began on the front lines as a physical therapist working in rural communities and VA hospitals, where he repeatedly saw patients abandon treatment simply because access to care was too difficult. That experience led him to ask a bold question: if mental health therapy can be delivered virtually, why not physical therapy?

In this conversation, Ashok shares how TheraNow built a telehealth platform that works inside healthcare workflows—not outside them. We explore why many virtual care startups fail, how AI-powered clinical documentation can improve therapist productivity, and what it takes to scale a digital health company while partnering with major health systems.

Ashok also discusses achieving Joint Commission accreditation, integrating with complex EHR environments, and building operational infrastructure that supports both clinicians and patients.

If you're interested in telehealth innovation, digital health startups, AI in healthcare, physical therapy, or healthcare workflow design, this episode offers practical insights on building virtual care platforms that actually work.

[June 24, 2026] Robots Are Coming To The Cath Lab. What if the future of interventional cardiology isn’t just better devices—but robotic precision?

In this episode of Med Tech Gurus, we sit down with Dr. Philippe Bencteux, founder and president of RoboCath, a pioneering company developing robotic platforms designed to transform cardiovascular and neurovascular interventions.

A neuroradiologist turned entrepreneur, Dr. Bencteux launched RoboCath after witnessing how access to specialized vascular expertise can determine whether patients live or die—particularly in hospitals lacking advanced interventional capabilities. His vision: bring robotic precision and eventually remote care to life-saving endovascular procedures.

We explore the evolution of RoboCath’s robotic systems, including the R1 platform, which demonstrated more than 98% technical success in multicenter studies, and the company’s next-generation system now entering first-in-human trials for coronary artery disease.

Dr. Bencteux shares how robotics can dramatically improve physician safety by reducing radiation exposure and physical strain in the cath lab, while also increasing procedural precision and enabling more complex interventions.

If you're interested in robotic surgery, interventional cardiology innovation, digital health, AI-driven medical devices, or the future of remote healthcare, this episode offers a fascinating look at how robotics could reshape the next era of cardiovascular treatment.

[June 17, 2026] Data Isn’t Strategy. AI can analyze data faster than any human—but strategy still requires judgment.

In this episode of Med Tech Gurus, we sit down with Joe Luminiello, Founder and CEO of RCG Intel, a competitive intelligence firm operating at the intersection of healthcare, biopharma, and AI-driven decision making. With more than 40 years of life sciences leadership experience—including helping launch Takeda’s Canadian business and leading a 650-person commercial organization responsible for over $1B in annual sales—Joe brings a unique perspective on what separates data from real strategic insight.

Joe explains why many life sciences companies struggle to translate information into action. While AI can rapidly analyze clinical data, market signals, and competitive activity, it cannot replace the contextual intelligence that comes from human conversations with physicians, key opinion leaders, and frontline healthcare professionals.

We explore how commercial teams can avoid the common disconnect between product development and market strategy, why cross-functional communication is critical for successful product launches, and how companies can use AI to enhance—not replace—human decision-making.

If you're a MedTech founder, biotech executive, investor, or commercial leader navigating AI, competitive intelligence, and product commercialization, this episode offers powerful insights into turning data into strategy and strategy into execution.

[June 10, 2026] Why Most Radiology AI Fails. AI can detect lung nodules in milliseconds—so why hasn’t radiology been transformed?

In this episode of Med Tech Gurus, we sit down with Khan Siddiqui, radiologist, serial entrepreneur, and CEO of HOPPR, to unpack why most AI tools in medical imaging struggle to survive beyond pilot studies.

Dr. Siddiqui explains that detection isn’t the real problem—workflow is. As imaging volumes surge and radiologist shortages intensify, AI must deliver measurable ROI in time savings, reporting efficiency, and reduced cognitive load. Tools that add clicks or increase reading time simply won’t scale.

We explore HOPPR’s AI-native platform, which accelerates model development, enables local fine-tuning, and integrates AI directly into existing clinical workflows. Khan also shares powerful lessons on fundraising, identifying “hair-on-fire” customers, building A-player teams, and scaling innovation responsibly in regulated healthcare environments.

If you care about AI in healthcare, radiology innovation, or moving from hype to real-world adoption, this episode delivers practical insight from one of the field’s pioneers.

[June 3, 2026] Rewriting the Rules of Pediatric Lumbar Puncture. What if one of pediatrics’ most common emergency procedures hasn’t meaningfully evolved in over a century?

In this episode of Med Tech Gurus, we sit down with Bob Cooper, CEO of SMoLTAP, to explore how a simple but powerful positioning innovation is transforming infant lumbar punctures.

For decades, pediatric spinal taps have relied on manual restraint, inconsistent positioning, and high failure rates—often leading to repeat attempts, unnecessary hospital admissions, and increased stress for clinicians and families. SMoLTAP’s positioning cradle stabilizes infants in a consistent seated posture, improving first-stick success rates, reducing procedural time, and minimizing the need for sedation.

Bob shares the origin story—from a frustrating clinical moment at Brown University to adoption in over 100 hospitals—and dives into the realities of pediatric medical device commercialization. We explore specialty distribution strategies, navigating value analysis committees, building ROI calculators, and scaling capital-efficiently in a challenging healthcare market.

This episode is a powerful example of how human-centered design, operational insight, and disciplined execution can change the standard of care.

[May 27, 2026] The Human Side of Medtech Innovation. Why do so many MedTech innovations fail to gain traction—even when the technology works exactly as designed?

In this episode of Med Tech Gurus, we’re joined by Erin Rollenhagen, Founder and CEO of People-Friendly Tech, UX strategist, and author of Love at First Launch. With experience leading over 200 successful technology launches across healthcare and other regulated industries, Erin brings a unique perspective on what truly drives product adoption.

Erin explains why usability and emotional connection often matter more than features alone—and why success depends on how both clinicians and patients feel when interacting with new technology. We explore how companies can preserve the original vision behind their innovations while navigating compliance, scaling challenges, and evolving market demands.

From designing onboarding experiences that build trust to using AI thoughtfully without overwhelming users, Erin shares how MedTech leaders can create solutions that align with real-world workflows and deliver meaningful outcomes.

If you’re a founder, executive, or investor looking to improve clinical adoption and scale innovation without losing the magic of your original idea, this episode offers practical insights into building technology people actually want to use.

[May 20, 2026] Fixing the Hidden Bottleneck in Healthcare. Why do hospitals invest millions in clinical innovation—yet still struggle to move patients down the hall?

In this episode of Med Tech Gurus, we sit down with Dr. David Crabb, emergency physician and CEO of Rovex, to explore one of healthcare’s most overlooked operational challenges: patient transport. Drawing on his dual experience in frontline emergency medicine and clinical informatics, Dr. Crabb shares how delays in moving patients between departments can quietly impact throughput, staff workload, and ultimately patient outcomes.

At Rovex, Dr. Crabb is leading the development of an autonomous mobile robot designed to attach to standard hospital stretchers—safely transporting patients while reducing delays, minimizing staff injuries, and helping clinicians work at the top of their license. We discuss how physical AI and robotics are moving beyond the digital world to address real-world inefficiencies inside hospitals.

From building trust in AI-driven systems to navigating adoption challenges in complex care environments, this episode explores what it takes to introduce an entirely new category of medical technology—and why solving logistical problems may be the key to unlocking better care delivery.

[May 13, 2026] The Product Adoption Lie: Why Great Medtech Fails to Scale. Why do so many breakthrough MedTech products fail — even when the technology works?

In this episode of Med Tech Gurus, we’re joined by Holley Miller, Founder and President of Grey Matter Marketing and one of the most direct, no-nonsense voices in healthcare commercialization today. With nearly three decades in life sciences — from the early days of surgical robotics to advising CEOs, boards, and investors — Holley has helped create more than $4.5 billion in enterprise value by doing one thing differently: designing adoption before launch.

Holley is the architect of what she calls the Product Adoption Lie — the dangerous belief that better products automatically win. In this conversation, she explains why most launches fail not because the product is weak, but because the market was never taught to change its beliefs or behavior. We explore why adoption must be engineered, how category design replaces traditional go-to-market playbooks, and why alignment across clinical, regulatory, and commercial teams is essential to changing the standard of care.

If you’re a founder, executive, or investor trying to scale innovation — not just launch a product — this episode delivers a hard truth and a clear roadmap for building something the market can’t ignore.

[May 6, 2026] When Every Minute is Critical: Scaling AI to Save Stroke Patients. What if frontline clinicians everywhere had instant access to expert-level stroke imaging — no matter where a patient arrives?

In this episode of Med Tech Gurus, we’re joined by Michalis Papadakis, CEO and Co-Founder of Brainomix, an Oxford University spin-out using AI to transform how stroke is diagnosed and treated. With a background in neuroscience from Imperial College London, UCL, and the University of Oxford, Michalis built Brainomix with a singular mission: ensure patients don’t miss out on life-saving stroke treatments due to delays or lack of imaging expertise.

Under his leadership, Brainomix developed Brainomix 360 Stroke, the world’s first fully automated AI imaging suite for stroke care — now deployed in more than 30 countries, backed by 50+ clinical publications, and processing patient scans in minutes with results delivered in under sixty seconds. In this conversation, we explore how starting with a true clinical unmet need, relentless evidence generation, and seamless workflow integration enabled Brainomix to scale globally and materially improve patient outcomes.

If you care about AI in healthcare, stroke innovation, clinical adoption, or scaling medtech from academia to enterprise, this is a blueprint worth hearing.

[April 29, 2026] From Signal to Scale: Turning Medtech Data into Growth. Why do so many great MedTech products stall after launch — even when the data is there?

In this episode of Med Tech Gurus, we’re joined by Amy Brouhle, Vice President of Strategic Business Development at S2N Health. A former emergency department nurse turned commercialization leader, Amy brings more than 20 years of experience spanning clinical care, GPO strategy, national accounts, and MedTech growth. Her career includes senior roles at Vizient, Hillrom, and GE Healthcare, giving her a rare, end-to-end view of how innovation actually gets adopted — or stuck.

At S2N Health, Amy helps MedTech companies cut through the noise of fragmented data and turn insight into action. We explore why most organizations don’t have a data problem — they have an insight problem — and how aligning sales, marketing, and strategy around the right signals can unlock utilization, accelerate adoption, and improve investor confidence.

From GPO dynamics and channel strategy to AI-powered targeting, territory planning, and go-to-market execution, Amy shares practical lessons every founder and commercial leader needs to hear. If you’re trying to translate innovation into revenue and scale, this is a conversation you won’t want to miss.

[April 22, 2026] From Acute Care to Continuous Care. Why has healthcare resisted digital transformation longer than almost any other industry?

In this episode of Med Tech Gurus, we’re joined by Mariano García-Valiño, four-time entrepreneur, digital health innovator, and CEO of AXENYA—recently named one of the world’s best digital health companies by Newsweek. Mariano has built, scaled, and exited billion-dollar healthcare companies by combining technology, data, and human-centered design to tackle chronic disease at scale.

Mariano is also the author of Inedible, where he argues that modern healthcare is still built for acute illness, not the chronic conditions driving today’s costs and outcomes. In this conversation, we explore why software alone isn’t enough, how AI and continuous care models unlock real impact, and what it actually takes to scale health tech in complex, regulated markets.

From leadership and entrepreneurship to AI-enabled care delivery, Mariano shares hard-earned lessons on building companies with both scale and purpose. If you care about digital health, healthcare transformation, or meaningful innovation, this is a conversation you won’t want to miss.

[April 15, 2026] Beating the Clock: Rethinking Brain Tumor Care. What if the most dangerous part of brain tumor treatment isn’t the surgery… but the wait that comes after it?

In this episode of Med Tech Gurus, we sit down with Dr. Michael Garcia, Chief Medical Officer and Head of Clinical Development at GT Medical Technologies, and one of the leading voices reshaping how we treat brain tumors. Dr. Garcia leads the clinical strategy behind GammaTile® — an implantable, bioabsorbable device that delivers targeted radiation from inside the brain immediately after surgery, eliminating the dangerous 3–6 week delay where tumors often begin to grow back.

Under his leadership, GT Medical has reported powerful interim clinical data showing GammaTile can reduce the risk of recurrence or death by more than 50% compared to standard of care — with no increase in safety concerns. Today, more than 150 leading cancer centers are using this technology, changing not only outcomes, but something equally important: patient experience. Less anxiety. Fewer treatment delays. Fewer logistical burdens. More hope.

Dr. Garcia shares the science, the strategy, and the deeply personal mission behind this innovation — along with insights on clinical trial design, multidisciplinary collaboration, and building medtech that truly serves patients. If you care about oncology, neurosurgery, innovation with purpose, or patient-centered design, this is a conversation you won’t want to miss.

[April 8, 2026] Stickers That Can Save Lives: The Future of Microwearable Health Monitoring. What happens when rocket-science precision meets frontline healthcare?

In this episode of Med Tech Gurus, we sit down with Professor Mark Kendall, Founder & CEO of WearOptimo and one of the world’s most visionary biomedical innovators. A former rocket scientist turned medtech pioneer, Mark has already transformed vaccine delivery with groundbreaking platforms like PowderJet and Vaxxas. Now, he’s doing it again — this time with a revolutionary micro-wearable sensor designed to pull high-fidelity biosignals directly from the skin without painful needles or invasive hardware.  

Mark explains how WearOptimo’s sticker-like microneedle patch, built using cutting-edge manufacturing techniques that scale to tens of millions of units, is redefining what wearables can do. The first target? Hydration monitoring — solving a problem so widespread it quietly reduces life expectancy and affects elite athletes, surgical outcomes, and everyday health. From scalable manufacturing and AI-enabled biomarker intelligence, to building elite teams and navigating fundraising, Mark delivers powerful lessons on innovation, leadership, and building technologies that truly matter. 

If you’re passionate about the future of wearable medicine, platform technology, and designing solutions that actually reach the real world, this conversation is one you won’t want to miss.